Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Woltering

Showing results (231-240 of 430) with videos related to

Pageof 43
Sort By:
Surgery, Gynecology & Obstetrics|June 1, 1990
Effect of somatostatin analog on peptide release and tumor growth in the Zollinger-Ellison syndromeE Mozell, E A Woltering, T M O'Dorisio, et al.
Chemmedchem|April 30, 2009
Mutagenesis and molecular modeling of the orthosteric binding site of the mGlu2 receptor determining interactions of the group II receptor antagonist (3)H-HYDIALinda Lundström, Bernd Kuhn, Jennifer Beck, et al.
Oncology Reports|January 5, 2007
Cell cycle regulating proteins p21 and p27 in prognosis of oral squamous cell carcinomasThomas Fillies, Mike Woltering, Burkhard Brandt, et al.
Plant Physiology and Biochemistry : PPB|November 3, 2006
Involvement of ethylene and lipid signalling in cadmium-induced programmed cell death in tomato suspension cellsE T Yakimova, V M Kapchina-Toteva, L-J Laarhoven, et al.
International Journal of Obesity (2005)|February 28, 2008
Enterostatin inhibition of angiogenesis: possible role of pAMPK and vascular endothelial growth factor A (VEGF-A)M Park, J Lyons, H Oh, et al.
Bioorganic & Medicinal Chemistry Letters|March 23, 2005
Novel heterocyclic thyromimeticsHelmut Haning, Michael Woltering, Ulrich Mueller, et al.
Bioorganic & Medicinal Chemistry Letters|March 6, 2003
An adjustable release rate linking strategy for cytotoxin-peptide conjugatesJoseph A Fuselier, Lichun Sun, S Nathaniel Woltering, et al.
British Journal of Pharmacology|April 8, 2011
Structural determinants of allosteric antagonism at metabotropic glutamate receptor 2: mechanistic studies with new potent negative allosteric modulatorsL Lundström, C Bissantz, J Beck, et al.
Brain Pathology (Zurich, Switzerland)|May 31, 2022
DNA methylation profiling of central nervous system hemangioblastomas identifies two distinct subgroupsNiklas Woltering, Anne Albers, Michael Müther, et al.
American Journal of Therapeutics|May 10, 2001
Prevention of contrast media-induced renal dysfunction with prostaglandin E1: a randomized, double-blind, placebo-controlled studyM H Sketch, A Whelton, E Schollmayer, et al.
Pageof 43

Showing results (231-240 of 430) with videos related to

Sort By:
Pageof 43
Surgery, Gynecology & Obstetrics|June 1, 1990
Effect of somatostatin analog on peptide release and tumor growth in the Zollinger-Ellison syndromeE Mozell, E A Woltering, T M O'Dorisio, et al.
Chemmedchem|April 30, 2009
Mutagenesis and molecular modeling of the orthosteric binding site of the mGlu2 receptor determining interactions of the group II receptor antagonist (3)H-HYDIALinda Lundström, Bernd Kuhn, Jennifer Beck, et al.
Oncology Reports|January 5, 2007
Cell cycle regulating proteins p21 and p27 in prognosis of oral squamous cell carcinomasThomas Fillies, Mike Woltering, Burkhard Brandt, et al.
Plant Physiology and Biochemistry : PPB|November 3, 2006
Involvement of ethylene and lipid signalling in cadmium-induced programmed cell death in tomato suspension cellsE T Yakimova, V M Kapchina-Toteva, L-J Laarhoven, et al.
International Journal of Obesity (2005)|February 28, 2008
Enterostatin inhibition of angiogenesis: possible role of pAMPK and vascular endothelial growth factor A (VEGF-A)M Park, J Lyons, H Oh, et al.
Bioorganic & Medicinal Chemistry Letters|March 23, 2005
Novel heterocyclic thyromimeticsHelmut Haning, Michael Woltering, Ulrich Mueller, et al.
Bioorganic & Medicinal Chemistry Letters|March 6, 2003
An adjustable release rate linking strategy for cytotoxin-peptide conjugatesJoseph A Fuselier, Lichun Sun, S Nathaniel Woltering, et al.
British Journal of Pharmacology|April 8, 2011
Structural determinants of allosteric antagonism at metabotropic glutamate receptor 2: mechanistic studies with new potent negative allosteric modulatorsL Lundström, C Bissantz, J Beck, et al.
Brain Pathology (Zurich, Switzerland)|May 31, 2022
DNA methylation profiling of central nervous system hemangioblastomas identifies two distinct subgroupsNiklas Woltering, Anne Albers, Michael Müther, et al.
American Journal of Therapeutics|May 10, 2001
Prevention of contrast media-induced renal dysfunction with prostaglandin E1: a randomized, double-blind, placebo-controlled studyM H Sketch, A Whelton, E Schollmayer, et al.
Pageof 43